These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 30773073

  • 1. Overcoming challenges of venous thromboembolism in sickle cell disease treatment.
    Ogunsile FJ, Naik R, Lanzkron S.
    Expert Rev Hematol; 2019 Mar; 12(3):173-182. PubMed ID: 30773073
    [Abstract] [Full Text] [Related]

  • 2. Sickle cell disease and venous thromboembolism: what the anticoagulation expert needs to know.
    Naik RP, Streiff MB, Lanzkron S.
    J Thromb Thrombolysis; 2013 Apr; 35(3):352-8. PubMed ID: 23435703
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. How I diagnose and treat venous thromboembolism in sickle cell disease.
    Shet AS, Wun T.
    Blood; 2018 Oct 25; 132(17):1761-1769. PubMed ID: 29764840
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Venous thromboembolism in pediatric patients with sickle cell disease: A north American survey on experience and management approaches of pediatric hematologists.
    Betensky M, Kumar R, Hankins JS, Goldenberg NA, Duration of Antithrombotic Therapy Working Group of the Pediatric and Neonatal Thrombosis and Haemostasis Subcommittee of the ISTH.
    Thromb Res; 2022 Mar 25; 211():133-139. PubMed ID: 35151008
    [Abstract] [Full Text] [Related]

  • 7. Venous thromboembolism incidence in the Cooperative Study of Sickle Cell Disease.
    Naik RP, Streiff MB, Haywood C, Segal JB, Lanzkron S.
    J Thromb Haemost; 2014 Dec 25; 12(12):2010-6. PubMed ID: 25280124
    [Abstract] [Full Text] [Related]

  • 8. Evaluating thromboprophylaxis in the sickle cell disease population: Navigating the evidence gap.
    Davila J, O'Brien SH, Mitchell WB, Manwani D.
    Br J Haematol; 2024 Jun 25; 204(6):2184-2193. PubMed ID: 38578212
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. High incidence of venous thromboembolism recurrence in patients with sickle cell disease.
    Brunson A, Keegan T, Mahajan A, White R, Wun T.
    Am J Hematol; 2019 Aug 25; 94(8):862-870. PubMed ID: 31074115
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prevalence and risk factors for venous thromboembolism in children with sickle cell disease: an administrative database study.
    Kumar R, Stanek J, Creary S, Dunn A, O'Brien SH.
    Blood Adv; 2018 Feb 13; 2(3):285-291. PubMed ID: 29431623
    [Abstract] [Full Text] [Related]

  • 14. Sex as an Independent Risk Factor for Venous Thromboembolism in Sickle Cell Disease: A Cross-Sectional Study.
    Roe AH, McAllister A, Kete C, Pishko A, Whitworth H, Schreiber CA, Sayani FA.
    J Womens Health (Larchmt); 2022 Oct 13; 31(10):1467-1471. PubMed ID: 35675680
    [Abstract] [Full Text] [Related]

  • 15. COVID-19 and venous thromboembolism risk in patients with sickle cell disease.
    Singh A, Brandow AM, Wun T, Shet AS.
    Blood Adv; 2022 Aug 09; 6(15):4408-4412. PubMed ID: 35763429
    [Abstract] [Full Text] [Related]

  • 16. Anticoagulation strategies and recurrence of venous thromboembolic events in patients with sickle cell disease: a systematic review and meta-analysis.
    El-Amin N, Iness A, Cyrus JW, Sisler I, Karam O.
    Ann Hematol; 2022 Sep 09; 101(9):1931-1940. PubMed ID: 35895101
    [Abstract] [Full Text] [Related]

  • 17. Contemporary treatment of venous thromboembolic disease.
    Galanis T, Merli GJ.
    Cardiol Clin; 2015 Feb 09; 33(1):49-57. PubMed ID: 25439330
    [Abstract] [Full Text] [Related]

  • 18. Enoxaparin adherence for venous thromboembolism prophylaxis in hospitalized patients with sickle cell disease.
    Sakon C, Nikirk M, O'Brien ARW.
    Expert Rev Hematol; 2023 Feb 09; 16(2):147-150. PubMed ID: 36576324
    [Abstract] [Full Text] [Related]

  • 19. Risk factors for venous thromboembolism in children.
    Gerotziafas GT.
    Int Angiol; 2004 Sep 09; 23(3):195-205. PubMed ID: 15765033
    [Abstract] [Full Text] [Related]

  • 20. Venous Thromboembolism in Individuals with Sickle Cell Disease: A Narrative Review.
    Raslan IA, Solh Z, Kuo KHM, Abdulrehman J.
    Hemoglobin; 2024 Jul 09; 48(4):231-243. PubMed ID: 39420740
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.